Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Receivables (2016 - 2017)

Armata Pharmaceuticals' Receivables history spans 5 years, with the latest figure at $15000.0 for Q1 2017.

  • For Q1 2017, Receivables rose 7.14% year-over-year to $15000.0; the TTM value through Mar 2017 reached $15000.0, up 7.14%, while the annual FY2016 figure was $12000.0, N/A changed from the prior year.
  • Receivables for Q1 2017 was $15000.0 at Armata Pharmaceuticals, up from $12000.0 in the prior quarter.
  • Across five years, Receivables topped out at $136000.0 in Q2 2014 and bottomed at $8000.0 in Q4 2013.
  • The 5-year median for Receivables is $18000.0 (2016), against an average of $36909.1.
  • The largest annual shift saw Receivables skyrocketed 1150.0% in 2014 before it plummeted 40.0% in 2016.
  • A 5-year view of Receivables shows it stood at $8000.0 in 2013, then surged by 1150.0% to $100000.0 in 2014, then plummeted by 60.0% to $40000.0 in 2015, then tumbled by 70.0% to $12000.0 in 2016, then increased by 25.0% to $15000.0 in 2017.
  • Per Business Quant, the three most recent readings for ARMP's Receivables are $15000.0 (Q1 2017), $12000.0 (Q4 2016), and $24000.0 (Q3 2016).